Navina, an AI-enabled scientific intelligence platform for main care suppliers, introduced the shut of a $55 million Sequence C funding spherical, bringing its whole increase to $100 million.
Development Fairness at Goldman Sachs Options led the spherical, with participation from current buyers Vertex Ventures Israel, ALIVE and Grove Ventures.
WHAT IT DOES
Navina gives suppliers, accountable care organizations, administration companies organizations and well being plans AI-enabled instruments for threat adjustment, chart assessment, high quality administration and analytics to assist monitor and optimize value-based care efficiency.
The New York-based firm will use the funds to broaden throughout the U.S. and advance its AI know-how.
“This funding is a strong validation of Navina’s imaginative and prescient to enhance affected person outcomes and healthcare economics by breaking down knowledge obstacles with AI,” Ronen Lavi, cofounder and CEO of Navina, stated in an announcement.
“We’re thrilled to companion with a best-in-class agency like Goldman Sachs, whose market management shall be instrumental as we enter this pivotal progress section and broaden our market attain. With this extra capital, we are going to proceed to speed up AI innovation and revolutionize healthcare by making each affected person interplay extra empathic, customized, and proactive.”
MARKET SNAPSHOT
In December, Navina introduced a strategic partnership with agilon well being, a platform geared toward serving to physicians higher serve their sufferers on the neighborhood degree.
Navina’s AI engine was built-in into agilon well being’s tech platform to enhance effectivity and support value-based care workflows for agilon’s well being community of two,800 main care physicians.
In 2023, the corporate partnered with doctor enablement firm Privia Well being Group, through which Privia would make the most of Navina’s AI to reinforce value-based care initiatives, workflows and affected person care.
In 2022, Navina secured $22 million in Sequence B funding, doubling its increase on the time to $44 million. A yr earlier than, the corporate raised $15 million in a Sequence A funding spherical and, in 2020, closed a $7 million seed funding spherical.
